Arkolith/Insider Trading/GTBP/Form 4

Ohri Manu

CFO & SecretaryGT Biopharma, Inc. (GTBP) · full profile →Form 4 · filed Aug 15, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Other(J)200K$0.29$58K300K
Aug 11, 2023Other(J)200K$0.29$58K0
Aug 11, 2023Grant(A)200K$0.29$58K200K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-029059) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML